+1 915 229 3004 (U.S.) | 
+44 7452 242832 (U.K.)
+1 915 229 3004 (U.S.) | +44 7452 242832 (U.K.)
Table of Contents:
1. Executive summary
2. Market Introduction
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
3. Research Methodology
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Modality
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. Market Dynamics
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. Market Factor Analysis
5.1. Value Chain Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. GLOBAL Retinal Drugs MARKET, BY Distribution Channel
6.1. Overview
6.2. Hospital pharmacy
6.3. Retail pharmacy
6.4. Online Pharmacy
7. GLOBAL Retinal Drugs MARKET, BY Indication
7.1. Overview
7.2. Macular degeneration
7.3. Diabetic eye disease
7.4. Others
8. GLOBAL Retinal Drugs MARKET, by Region
8.1. Overview
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.3. Europe
8.3.1. Germany
8.3.2. France
8.3.3. U.K
8.3.4. Italy
8.3.5. Spain
8.3.6. Rest of Europe
8.4. Asia-Pacific
8.4.1. China
8.4.2. India
8.4.3. Japan
8.4.4. South Korea
8.4.5. Australia
8.4.6. Rest of Asia-Pacific
8.5. Rest of the World
8.5.1. Middle East
8.5.2. Africa
8.5.3. Latin America
9. Competitive Landscape
9.1. Overview
9.2. Competitive Analysis
9.3. Market Share Analysis
9.4. Major Growth Strategy in the Global Retinal Drugs Market,
9.5. Competitive Benchmarking
9.6. Leading Players in Terms of Number of Developments in the Global Retinal Drugs Market,
9.7. Key developments and Growth Strategies
9.7.1. New Distribution Channel Launch/Indication Deployment
9.7.2. Merger & Acquisitions
9.7.3. Joint Ventures
9.8. Major Players Financial Matrix
9.8.1. Sales & Operating Income, 2022
9.8.2. Major Players R&D Expenditure. 2022
10. Company ProfileS
10.1. Bayer AG
10.1.1. Company Overview
10.1.2. Financial Overview
10.1.3. Product Offered
10.1.4. Key Developments
10.1.5. SWOT Analysis
10.1.6. Key Strategies
10.2. ALCON INC.
10.2.1. Company Overview
10.2.2. Financial Overview
10.2.3. Product Offered
10.2.4. Key Developments
10.2.5. SWOT Analysis
10.2.6. Key Strategies
10.3. Alimera Sciences Inc.
10.3.1. Company Overview
10.3.2. Financial Overview
10.3.3. Product Offered
10.3.4. Key Developments
10.3.5. SWOT Analysis
10.3.6. Key Strategies
10.4. Bausch Health Co Inc.
10.4.1. Company Overview
10.4.2. Financial Overview
10.4.3. Product Offered
10.4.4. Key Developments
10.4.5. SWOT Analysis
10.4.6. Key Strategies
10.5. Bristol Myers Squibb Co.
10.5.1. Company Overview
10.5.2. Financial Overview
10.5.3. Product Offered
10.5.4. Key Developments
10.5.5. SWOT Analysis
10.5.6. Key Strategies
10.6. F. Hoffmann La Roche Ltd.
10.6.1. Company Overview
10.6.2. Financial Overview
10.6.3. Product Offered
10.6.4. Key Developments
10.6.5. SWOT Analysis
10.6.6. Key Strategies
10.7. Kubota Corp.
10.7.1. Company Overview
10.7.2. Financial Overview
10.7.3. Product Offered
10.7.4. Key Developments
10.7.5. SWOT Analysis
10.7.6. Key Strategies
10.8. MeiraGTx Holdings Plc
10.8.1. Company Overview
10.8.2. Financial Overview
10.8.3. Product Offered
10.8.4. Key Developments
10.8.5. SWOT Analysis
10.8.6. Key Strategies
10.9. Novartis AG
10.9.1. Company Overview
10.9.2. Financial Overview
10.9.3. Product Offered
10.9.4. Key Developments
10.9.5. SWOT Analysis
10.9.6. Key Strategies
11. Appendix
11.1. References
11.2. Related Reports
LIST OF TABLES
TABLE 1 Global Retinal Drugs Market, Synopsis, 2018-2032
TABLE 2 Global Retinal Drugs Market, Estimates & Forecast, 2018-2032 (USD BILLION)
TABLE 3 GLOBAL Retinal Drugs MARKET, BY Distribution Channel, 2018-2032 (USD BILLION)
TABLE 4 GLOBAL Retinal Drugs MARKET, BY INDICATION, 2018-2032 (USD BILLION)
TABLE 5 North America Retinal Drugs MARKET, BY Distribution Channel, 2018-2032 (USD BILLION)
TABLE 6 North America Retinal Drugs MARKET, BY INDICATION, 2018-2032 (USD BILLION)
TABLE 7 North America Retinal Drugs MARKET, BY Country, 2018-2032 (USD BILLION)
TABLE 8 U.S. Retinal Drugs MARKET, BY Distribution Channel, 2018-2032 (USD BILLION)
TABLE 9 U.S. Retinal Drugs MARKET, BY INDICATION, 2018-2032 (USD BILLION)
TABLE 10 Canada Retinal Drugs MARKET, BY Distribution Channel, 2018-2032 (USD BILLION)
TABLE 11 Canada Retinal Drugs MARKET, BY INDICATION, 2018-2032 (USD BILLION)
TABLE 12 Europe Retinal Drugs MARKET, BY Distribution Channel, 2018-2032 (USD BILLION)
TABLE 13 Europe Retinal Drugs MARKET, BY INDICATION, 2018-2032 (USD BILLION)
TABLE 14 Europe Retinal Drugs MARKET, BY Country, 2018-2032 (USD BILLION)
TABLE 15 Germany Retinal Drugs MARKET, BY Distribution Channel, 2018-2032 (USD BILLION)
TABLE 16 Germany Retinal Drugs MARKET, BY INDICATION, 2018-2032 (USD BILLION)
TABLE 17 France Retinal Drugs MARKET, BY Distribution Channel, 2018-2032 (USD BILLION)
TABLE 18 France Retinal Drugs MARKET, BY INDICATION, 2018-2032 (USD BILLION)
TABLE 19 Italy Retinal Drugs MARKET, BY Distribution Channel, 2018-2032 (USD BILLION)
TABLE 20 Italy Retinal Drugs MARKET, BY INDICATION, 2018-2032 (USD BILLION)
TABLE 21 Spain Retinal Drugs MARKET, BY Distribution Channel, 2018-2032 (USD BILLION)
TABLE 22 Spain Retinal Drugs MARKET, BY INDICATION, 2018-2032 (USD BILLION)
TABLE 23 U.K Retinal Drugs MARKET, BY Distribution Channel, 2018-2032 (USD BILLION)
TABLE 24 U.K Retinal Drugs MARKET, BY INDICATION, 2018-2032 (USD BILLION)
TABLE 25 Rest of Europe Retinal Drugs MARKET, BY Distribution Channel, 2018-2032 (USD BILLION)
TABLE 26 Rest of Europe Retinal Drugs MARKET, BY INDICATION, 2018-2032 (USD BILLION)
TABLE 27 Asia Pacific Retinal Drugs MARKET, BY Distribution Channel, 2018-2032 (USD BILLION)
TABLE 28 Asia Pacific Retinal Drugs MARKET, BY INDICATION, 2018-2032 (USD BILLION)
TABLE 29 Asia Pacific Retinal Drugs MARKET, BY Country, 2018-2032 (USD BILLION)
TABLE 30 Japan Retinal Drugs MARKET, BY Distribution Channel, 2018-2032 (USD BILLION)
TABLE 31 Japan Retinal Drugs MARKET, BY INDICATION, 2018-2032 (USD BILLION)
TABLE 32 China Retinal Drugs MARKET, BY Distribution Channel, 2018-2032 (USD BILLION)
TABLE 33 China Retinal Drugs MARKET, BY INDICATION, 2018-2032 (USD BILLION)
TABLE 34 India Retinal Drugs MARKET, BY Distribution Channel, 2018-2032 (USD BILLION)
TABLE 35 India Retinal Drugs MARKET, BY INDICATION, 2018-2032 (USD BILLION)
TABLE 36 Australia Retinal Drugs MARKET, BY Distribution Channel, 2018-2032 (USD BILLION)
TABLE 37 Australia Retinal Drugs MARKET, BY INDICATION, 2018-2032 (USD BILLION)
TABLE 38 south korea Retinal Drugs MARKET, BY Distribution Channel, 2018-2032 (USD BILLION)
TABLE 39 south korea Retinal Drugs MARKET, BY INDICATION, 2018-2032 (USD BILLION)
TABLE 40 Rest of asia-pacific Retinal Drugs MARKET, BY Distribution Channel, 2018-2032 (USD BILLION)
TABLE 41 Rest of asia-pacific Retinal Drugs MARKET, BY INDICATION, 2018-2032 (USD BILLION)
TABLE 42 Rest of WOrld Retinal Drugs MARKET, BY Distribution Channel, 2018-2032 (USD BILLION)
TABLE 43 Rest of WOrld Retinal Drugs MARKET, BY INDICATION, 2018-2032 (USD BILLION)
TABLE 44 Rest of WOrld Retinal Drugs MARKET, BY Country, 2018-2032 (USD BILLION)
TABLE 45 Middle east Retinal Drugs MARKET, BY Distribution Channel, 2018-2032 (USD BILLION)
TABLE 46 Middle east Retinal Drugs MARKET, BY INDICATION, 2018-2032 (USD BILLION)
TABLE 47 Africa Retinal Drugs MARKET, BY Distribution Channel, 2018-2032 (USD BILLION)
TABLE 48 Africa Retinal Drugs MARKET, BY INDICATION, 2018-2032 (USD BILLION)
TABLE 49 Latin america Retinal Drugs MARKET, BY Distribution Channel, 2018-2032 (USD BILLION)
TABLE 50 Latin america Retinal Drugs MARKET, BY INDICATION, 2018-2032 (USD BILLION)
LIST OF FIGURES
FIGURE 1 Research Process
FIGURE 2 Market Structure for the Global Retinal Drugs Market
FIGURE 3 Market Dynamics for the Global Retinal Drugs Market
FIGURE 4 Global Retinal Drugs Market, Share (%), BY Distribution Channel, 2022
FIGURE 5 Global Retinal Drugs Market, Share (%), BY INDICATION, 2022
FIGURE 6 Global Retinal Drugs Market, Share (%), by Region, 2022
FIGURE 7 north AMERICA: Retinal Drugs MARKET, SHARE (%), BY REGION, 2022
FIGURE 8 Europe: Retinal Drugs MARKET, SHARE (%), BY REGION, 2022
FIGURE 9 Asia-Pacific: Retinal Drugs MARKET, SHARE (%), BY REGION, 2022
FIGURE 10 Rest of the world: Retinal Drugs MARKET, SHARE (%), BY REGION, 2022
FIGURE 11 Global Retinal Drugs Market: Company Share Analysis, 2022 (%)
FIGURE 12 Bayer AG: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 13 Bayer AG: SWOT ANALYSIS
FIGURE 14 ALCON INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 15 ALCON INC.: SWOT ANALYSIS
FIGURE 16 Alimera Sciences Inc.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 17 Alimera Sciences Inc.: SWOT ANALYSIS
FIGURE 18 Bausch Health Co Inc.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 19 Bausch Health Co Inc.: SWOT ANALYSIS
FIGURE 20 Bristol Myers Squibb Co..: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 21 Bristol Myers Squibb Co..: SWOT ANALYSIS
FIGURE 22 F. Hoffmann La Roche Ltd.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 23 F. Hoffmann La Roche Ltd.: SWOT ANALYSIS
FIGURE 24 Kubota Corp.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 25 Kubota Corp.: SWOT ANALYSIS
FIGURE 26 MeiraGTx Holdings Plc: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 27 MeiraGTx Holdings Plc: SWOT ANALYSIS
FIGURE 28 Novartis AG: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 29 Novartis AG: SWOT ANALYSIS
Report Code :
RL6580
Published on :
Aug 2023
Request a Free Sample Report
Speak to Analyst